Rare diseases
Investigational molecules
Locations
Back to Poland1 clinical trial in Minsk Mazowiecki, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on acute heart failure management and treatment optimization. Research explores the effectiveness of innovative therapies using SGLT-2 inhibitors for improving patient outcomes.
This comprehensive study examines treatment responses across various heart failure categories, including reduced, mid-range, and preserved ejection fraction, advancing our understanding of cardiac care.
Groundbreaking research comparing the efficacy of Empagliflozin and Dapagliflozin in treating acute cardiac conditions. The study encompasses patients regardless of their diabetes status.
This initiative aims to enhance treatment protocols for hospitalized patients experiencing acute cardiac episodes, potentially revolutionizing standard care approaches.
Investigation into the broader applications of SGLT-2 inhibitor therapy in acute medical settings. The research explores treatment effectiveness across diverse patient populations.
This research contributes to developing more effective treatment strategies for acute cardiac conditions, potentially improving patient care standards.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
